www.hemonctoday.com/article.aspx?rid=42620 -
[Cached Version]
Published on: 8/10/2009
Last Visited: 8/22/2009
Data from the National Polyp Study, led by Sidney Winawer, MD, MACG, Paul Sherlock Chair in Medicine, and attending physicians on the GI and nutrition service at Memorial Sloan-Kettering Cancer Center, demonstrated that colonoscopy was associated with a significant decrease in colon cancer incidence, ranging from 76% to 90%.
...
Winawer agrees, noting that recent studies have indicated that time to withdrawal is not necessarily the key, but that colonoscopists with slower withdrawal times are more likely to perform more meticulous exams.
...
“This trial is going to give us a lot of information that we need,” Winawer said.
He and others tried to launch a similar study nearly 15 years ago, but the National Cancer Institute was not interested.
According to Winawer, however, the NordICC trial is timelier due to the number of questions that have been raised about the value of screening colonoscopy.
...
“This is just the beginning of quality assurance in this field,” Winawer said.
“We became cognizant of this just within the last few years, and we have to understand that screening colonoscopy is relatively new.”
In addition to guidelines and recommendations, the ASGE is spearheading a national endoscopic database reporting system to track individual and group performance.
Public awareness is also a priority, not only to increase screening rates but to educate the public about the uniqueness of colon cancer screening.
Patients should not only be aware of the high prevalence of colon cancer but also of the fact that it is highly preventable, Winawer said.
...
“We need to keep hammering away and increasing awareness,” Winawer said.